International Psoriasis Council
About the International Psoriasis Council (IPC)
Founded in 2004, the International Psoriasis Council (IPC) is a dermatology-led, voluntary, global nonprofit organization dedicated to innovation across the full spectrum of psoriasis through research, education and patient care.
Mission:
Our mission is to improve the health and well-being of people with psoriasis and associated diseases worldwide through education, research, and advocacy.
Vision:
Our vision is a world free of the burden of psoriasis. People with psoriasis worldwide should have access to the best available care and be empowered to lead healthy, fulfilling lives.
Transcriptomic Profiling of Hyperkeratotic Hand Eczema Skin | Weixin Zhou | Netherlands
IL-34 Expression and Function in Hidradenitis Suppurativa and Psoriasis | Emanuele Scala, PhD| Italy
Mechanisms of Topical Drug Delivery: Opportunities for Psoriasis?| Robert Rissmann, PhD| Netherlands
Paradoxical Psoriasis and Therapeutic Approaches | Paola DiMeglio, PhD | United Kingdom
Oral Drug Development: History and Future Prospects | Curdin Conrad, MD | Switzerland
Drug Induced Psoriasis | Deepak Balak, MD, PhD, MSc | Netherlands
Predicting Probability of Psoriasis Biologic Drug Continuation | Amaani Hussain | United Kingdom
IPC at CDA: Insights and Conversations with Psoriasis Experts
Mesenchymal Stromal Cells (MSCs) for Biologic-Refractory Psoriasis | Chris Griffiths, Su Lwin | UK
Case Presentation I: Special Populations | Priscilla Angwenyi, MD | Kenya
Psoriasis in Darker Skin Tones | Angela Londoño, MSc, MD | Colombia
Addressing the Itching and Pain of Psoriasis | Martin Steinhoff, MD, PhD | Qatar
Psoriasis in the Elderly | Peter van de Kerkhof, MD, PhD | Netherlands
Overview of Differential Diagnosis | Bruce Strober, MD, PhD | United States
Case Presentation: Differential Diagnosis | Lily Lyra Tumalad, MD, FPDS | Philippines
Case Presentation I: Psoriasis Symptoms | Romina Contreras, MSc, MD | Paraguay
Case Presentation II: Psoriasis Symptoms | Josep Riera-Monroig, MD | Spain
Case Presentation II: Special Populations | María Julia Cura, MD | Argentina
Women, Hormones & Psoriasis: From Pregnancy to Menopause |Yi Xiao, MD, PhD, MPH | China
Exploring Precision Treatment of Specific Psoriasis Subtypes Based on Pathogenic Mechanisms
Insights into Psoriasis and Its Comorbidities | Paolo Gisondi, MD | Italy
IPC at NPF Future Leaders 2025
Does Conventional Systemic Therapy Still Have a Place in Psoriasis? | Manuel Franco, MD | Colombia
Systemic Treatment of Psoriasis in High Impact Sites | Jeffrey Cohen, MD, MPH | United States
Interpreting Clinical & Real-World Evidence in Targeted Therapy | Stefano Piaserico, MD, PhD | Italy
Psoriasis Look-Alikes: TNF Inhibitor-Induced Psoriasiform Dermatitis | Amy Paller, MS, MD | USA
Global Collaborations in Consensus Building | Siew Eng Choon, MBBS, FRCP | Malaysia
Global Collaborations in Psoriasis Epidemiology |Christopher Griffiths, MD, FMedSci | United Kingdom
Phototherapy in Pediatric Psoriasis | Fernando Valenzuela, MD | Chile
Conventional Therapies: Topical & Systemic Use in Pediatric Psoriasis | Mona El-Kalioby, MD | Egypt